Founderland Logofounderland
the ★ top ★ 100 ★ marketers ★
SavedSearch
FoundersFounders
Fintech iconFintechClimate / Social Tech iconClimate / Social TechSaaS iconSaaSHealthtech & Biotech iconHealthtech & BiotecheCommerce iconeCommerceMedia & Entertainment iconMedia & Entertainment
Fintech iconFintechClimate / Social Tech iconClimate / Social TechSaaS iconSaaSHealthtech & Biotech iconHealthtech & BiotecheCommerce iconeCommerceMedia & Entertainment iconMedia & Entertainment
Fintech iconFintechClimate / Social Tech iconClimate / Social TechSaaS iconSaaSHealthtech & Biotech iconHealthtech & BiotecheCommerce iconeCommerceMedia & Entertainment iconMedia & Entertainment
Product Launches
Industries
Fintech iconFintechClimate / Social Tech iconClimate / Social TechSaaS iconSaaSHealthtech & Biotech iconHealthtech & BiotecheCommerce iconeCommerceMedia & Entertainment iconMedia & Entertainment
Investment News
Industries
Fintech iconFintechClimate / Social Tech iconClimate / Social TechSaaS iconSaaSHealthtech & Biotech iconHealthtech & BiotecheCommerce iconeCommerceMedia & Entertainment iconMedia & Entertainment
Research & Innovation
Industries
Fintech iconFintechClimate / Social Tech iconClimate / Social TechSaaS iconSaaSHealthtech & Biotech iconHealthtech & BiotecheCommerce iconeCommerceMedia & Entertainment iconMedia & Entertainment
FoundersFounders
514

Yash Rathod

Logo
Yash Rathod
CEO & Co-Founder of
Origin Bio (2011)
About

Yash Rathod is Co-Founder at Origin, an AI biotechnology company developing models for gene therapy design and regulatory DNA prediction. Origin launched Axis, the first AI model that generates regulatory DNA elements and predicts their function, outperforming Google DeepMind's AlphaGenome by 6.7%.

Before founding

Yash studied Computer Science at the University of Illinois Urbana-Champaign and previously worked at Resolvd AI. He grew up in India with aspirations of becoming a professional cricketer before transitioning to technology and entrepreneurship.

Founder Insights

Yash ranked 2nd in the Asia Region of the ICPC programming competition and 3rd in the All India ISPC programming competition. He previously took a gap year to pursue a startup venture before returning to complete his college education.

Experience

Origin is pioneering Frontier AI for Biology, using advanced machine learning to accelerate genetic discovery and therapy design. The company's team includes engineers and biologists from leading institutions including NVIDIA, Berkeley, Dartmouth, UPenn, and UIUC.

Scale & Impact

Axis represents a breakthrough in rational design of genetic therapies, enabling researchers to tailor genetic control systems with unprecedented precision. The model could reduce failure rates in gene therapy trials and enable faster, safer therapeutic development for complex diseases.

514

Yash Rathod

Origin BioOrigin
Co-Founder
Logo
Yash Rathod

Company(s)

Origin Bio+1

Industry

Healthtech & Biotech

Stage/Funding

N/A

Company Location

us

Connect

About

Yash Rathod is Co-Founder at Origin, an AI biotechnology company developing models for gene therapy design and regulatory DNA prediction. Origin launched Axis, the first AI model that generates regulatory DNA elements and predicts their function, outperforming Google DeepMind's AlphaGenome by 6.7%.

Before founding

Yash studied Computer Science at the University of Illinois Urbana-Champaign and previously worked at Resolvd AI. He grew up in India with aspirations of becoming a professional cricketer before transitioning to technology and entrepreneurship.

Founder Insights

Yash ranked 2nd in the Asia Region of the ICPC programming competition and 3rd in the All India ISPC programming competition. He previously took a gap year to pursue a startup venture before returning to complete his college education.

Experience

Origin is pioneering Frontier AI for Biology, using advanced machine learning to accelerate genetic discovery and therapy design. The company's team includes engineers and biologists from leading institutions including NVIDIA, Berkeley, Dartmouth, UPenn, and UIUC.

Scale & Impact

Axis represents a breakthrough in rational design of genetic therapies, enabling researchers to tailor genetic control systems with unprecedented precision. The model could reduce failure rates in gene therapy trials and enable faster, safer therapeutic development for complex diseases.

About

Dreamwell AIContact UsOur Story

Articles

Product LaunchesInvestment NewsResearch & Innovation

founderland

We Use Cookies

We baked up some cookies – the digital kind. They help Draper run like a well-oiled mid-century machine. Some are essential to the experience, others help us tailor things to your taste. We promise, no crumbs on your blazer. Take a moment to choose what works for you.